Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing

Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important therapeutic options in metastatic colorectal cancer (CRC). However, almost all patients with clinical response to anti-EGFR therapies show disease progression wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Sumitra, Heitzer, Ellen, Ulz, Peter, Lafer, Ingrid, Lax, Sigurd, Auer, Martina, Pichler, Martin, Gerger, Armin, Eisner, Florian, Hoefler, Gerald, Bauernhofer, Thomas, Geigl, Jochen B., Speicher, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967949/
https://www.ncbi.nlm.nih.gov/pubmed/24676216
http://dx.doi.org/10.1371/journal.pgen.1004271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967949/
https://www.ncbi.nlm.nih.gov/pubmed/24676216
http://dx.doi.org/10.1371/journal.pgen.1004271

Ejemplares similares